PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis

PARP inhibitors are used in the treatment of gynecological malignancies and it has been demonstrated in preclinical studies that PARP inhibition sensitizes cancer cells to cytotoxic agents. In the present study, PARP expression was detected in different endometrial cancer cell lines by western blot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Dinkic, Christine, Jahn, Friederike, Zygmunt, Marek, Schuetz, Florian, Rom, Joachim, Sohn, Christof, Fluhr, Herbert
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403547/
https://ncbi.nlm.nih.gov/pubmed/28454476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados